Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis.
- Egileak:
- Manterola A, Bernal-Chico A, Cipriani R, Ruiz A, Pérez-Samartín A, Moreno-Rodríguez M, Hsu KL, Cravatt BF, Brown JM, Rodríguez-Puertas R, Matute C, Mato S
- Urtea:
- 2018
- Non argitaratua:
- Neuropharmacology.
- Liburukia:
- 141:181-191.
- DOI:
- 10.1016/j.neuropharm.2018.08.038.